NASDAQ:AEHR

Aehr Test Systems (NASDAQ: AEHR) Gains Momentum with Strong Orders and Analyst 'Buy' Rating

Font: Financial Modeling Prep  • Aug 14, 2026

Market Chart
  • Investment firm Jefferies initiated a "Buy" rating for Aehr Test Systems, signaling positive analyst sentiment and a projected increase in its stock price.
  • Aehr Test Systems secured a significant $22 million follow-on order for its wafer-level burn-in systems, boosting its backlog to a robust $100.6 million.
  • Despite a strong stock surge of 72.2% and a premium valuation of 24.62 times forward sales, the company's financial health and growth prospects in the semiconductor testing market remain robust.

Aehr Test Systems (NASDAQ: AEHR) provides advanced test and burn-in solutions for critical semiconductor devices. These specialized systems are crucial for ensuring the reliability of chips used across high-growth sectors like artificial intelligence (AI), data centers, and automotive electronics. In the competitive semiconductor testing market, Aehr Test Systems competes with established firms such as Teradyne, Inc. (NASDAQ: TER) and Cohu, Inc. (NASDAQ: COHU), which have experienced varied stock performance recently.

On August 13, 2026, investment firm Jefferies initiated coverage on Aehr Test Systems with a "Buy" rating. This positive investment outlook was announced when the semiconductor stock was priced at $123.30. A "Buy" rating indicates that the firm's analysts believe the stock's price is likely to increase in the near future, reflecting strong confidence in the company's growth prospects.

This favorable rating follows significant positive news for Aehr Test Systems. As reported by Accesswire, Aehr Test Systems recently secured a $22 million follow-on order from a major AI processor customer. The order is specifically for its advanced wafer-level burn-in systems, which are designed to test entire silicon wafers at once to efficiently identify faulty chips early in the production process, enhancing semiconductor manufacturing efficiency.

The company's financial health further supports this optimism and positive market outlook. Aehr Test Systems reports record quarterly bookings of $60.7 million, contributing to a strong backlog of $100.6 million. A backlog represents confirmed orders that will be fulfilled and recognized as revenue in the future, providing clear visibility into the company's expected financial performance and future revenue growth.

Investor confidence in Aehr Test Systems is notably high, with the stock surging 72.2% over the past month, as highlighted by Zacks Investment Research. However, the stock currently trades at 24.62 times its forward sales, a high multiple compared to the industry average of 6.32. This premium valuation suggests that investors have significant growth expectations built into the current stock price, positioning Aehr Test Systems as a notable growth stock in the tech sector.

Market Overview
MDXH
MDxHealth S.A.
$0.81
74.89%
SURG
SurgePays, Inc.
$0.28
14.36%
VBIO
Valion Bio, Inc.
$0.19
11.59%
NU
Nu Holdings Ltd.
$15.23
9.33%
TSLL
Direxion Daily TSLA Bull 2X ETF
$8.76
1.39%
OTLK
Outlook Therapeutics, Inc.
$0.76
-14.90%
ONDS
Ondas Holdings Inc.
$9.24
3.70%
SPCX
Space Exploration Technologies Corp.
$140.00
-0.91%
INTC
Intel Corp.
$102.50
-1.97%
ONFO
Onfolio Holdings, Inc.
$2.59
12.12%